Genitourinary Cancer
Latest News
ASCO details how to manage ongoing cancer drug shortage
“This guidance document aims to support clinicians, as they navigate the complexities of treatment planning amid the drug shortage.”
From the Journals
MRIs, MRI-guided biopsies detect prostate cancer affordably
There is “a growing consensus that the use of MRI and potential MRI-guided biopsy is cost effective.”
Latest News
Black men are at higher risk of prostate cancer at younger ages, lower PSA levels
A large Veterans Affairs study finds that Black men with a prebiopsy PSA level of 4.0 ng/mL had the same risk of prostate cancer as White men with...
Conference Coverage
Enfortumab vedotin/pembrolizumab hailed as new standard for upfront mUC
After decades of stagnation, an almost doubling of life expectancy has set a new bar for the first-line treatment of locally advanced/metastatic...
Conference Coverage
Enzalutamide improves metastasis-free survival, QoL in prostate cancer
“This is the first time we have seen this kind of results with a novel hormonal therapy without castration.”
Latest News
Active surveillance preferred in low-risk prostate cancer
There was no difference in outcomes between treatment and active surveillance.
Conference Coverage
Observation, not radiotherapy, after radical prostatectomy
The investigators observed no benefit to adjuvant radiotherapy after radical prostatectomy in patients with prostate cancer in the phase 3...
From the Journals
Doublet therapy ups survival in metastatic prostate cancer
“A clinically meaningful increase in long-term survival was observed in men diagnosed with de novo [metastatic castration-sensitive prostate...
Conference Coverage
Short-course SBRT: Standard of care in prostate cancer?
Stereotactic body radiation therapy delivered in five fractions provided similar 5-year disease control as conventional, higher-dose external-beam...
Latest News
Is this the best screening test for prostate cancer?
Researchers from the United Kingdom found that half of men with apparently “safe” PSA levels had clinically significant prostate cancers when...
Latest News
BCR is unreliable surrogate for overall survival in prostate cancer
The correlation between BCR-free survival and overall survival ranged from low to moderate.